Advanced piperazine-containing inhibitors target microbial β-glucuronidases linked to gut toxicity
0301 basic medicine
Chemistry
03 medical and health sciences
DOI:
10.1039/d4cb00058g
Publication Date:
2024-07-16T08:31:25Z
AUTHORS (18)
ABSTRACT
Leveraging medicinal chemistry and structural biology to optimize microbial GUS inhibitors to UNC10206581, which displays potent L1 and FMN GUS activity – the structural subclasses linked to GI toxicity via small molecule glucuronide reactivation.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (37)
CITATIONS (1)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....